Sunflower (300111.SZ) intends to acquire 100% equity of Xipu material and 40% equity of Beide pharmaceutical, and the stock will resume trading.

Zhtng Cijng APP News, Sunflower (300111.SZ) announced that the company plans to purchase 100% equity of Xp Materials held by six trading partners, including Shanghai Xp, through issuing shares and paying cash. The company also intends to purchase 40% equity of Bid Pharmaceutical held by Sunflower Investment and raise matching funds. The company's stock will resume trading on Monday, September 22, 2025.